E-LIB Suche - Ergebnisse für: Mark D. Danese

1

Reply to "Letter to Dobesh et al. on lower mortality with a..:

Dobesh, Paul P. ; Fermann, Gregory J. ; Christoph, Mary J....
Research and Practice in Thrombosis and Haemostasis. 8 (2024) 4 - p. 102429 , 2024

Link: https://doi.org/10.1016/..

2

Treatment Patterns and Survival in Locally Advanced or Meta..:

Danese, Mark D. ; Mody, Kabir ; Thota, Ramya...
Gastro Hep Advances. 2 (2023) 4 - p. 580-587 , 2023

Link: https://doi.org/10.1016/..

3

Hereditary Angioedema With Normal C1 Inhibitor: US Survey o..:

Riedl, Marc A. ; Danese, Mark ; Danese, Sherry...
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 8 - p. 2450-2456.e6 , 2023

Link: https://doi.org/10.1016/..

4

Lower mortality with andexanet alfa vs 4-factor prothrombin..:

Dobesh, Paul P. ; Fermann, Gregory J. ; Christoph, Mary J....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) 6 - p. 102192 , 2023

Link: https://doi.org/10.1016/..

5

The rate, cost and outcomes of parathyroidectomy in the uni..:

Danese, Mark D ; Fox, Kathleen M ; Duryea, Jennifer L...
BMC Nephrology. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

6

Real-world Outcomes with Second-Line Therapy in Advanced Es..:

Danese, Mark ; Gricar, Joseph ; Abraham, Pranav
Future Oncology. 18 (2022) 8 - p. 927-936 , 2022

Link: https://doi.org/10.2217/..

7

Association Between Granulocyte Colony-Stimulating Factor (..:

Danese, Mark D. ; Schenfeld, Jennifer ; Shaw, Jaime...
Advances in Therapy. 39 (2022) 6 - p. 2778-2795 , 2022

Link: https://doi.org/10.1007/..

8

Longitudinal evaluation of treatment patterns, risk factors..:

Danese, Mark ; Sidelnikov, Eduard ; Villa, Guillermo...
BMJ Open. 12 (2022) 4 - p. e055015 , 2022

Link: https://doi.org/10.1136/..

9

Treatment patterns and outcomes in older patients with adva..:

Danese, Mark D. ; Daumont, Melinda ; Nwokeji, Esmond...
Cancer Reports. 5 (2021) 9 - p. , 2021

Link: https://doi.org/10.1002/..

10

A comparison of mixture cure fraction models to traditional..:

Roth, Joshua A. ; Yuan, Yong ; Othus, Megan...
Journal of Medical Economics. 24 (2021) 1 - p. 79-86 , 2021

Link: https://doi.org/10.1080/..

11

Fibroblast growth factor 23 as a risk factor for cardiovasc..:

Block, Geoffrey A. ; Chertow, Glenn M. ; Cooper, Kerry...
Hemodialysis International. 25 (2020) 1 - p. 78-85 , 2020

Link: https://doi.org/10.1111/..

12

Diabetic Population-Based Model to Estimate Impact of Ranib..:

Varma, Rohit ; Bressler, Neil M ; Doan, Quan V...
Clinical Ophthalmology. 14 (2020) - p. 1249-1259 , 2020

Link: https://doi.org/10.2147/..

13

Estimation of the increased risk associated with recurrent ..:

Danese, Mark D ; Pemberton-Ross, Peter ; Catterick, David.
European Journal of Preventive Cardiology. 28 (2020) 3 - p. 335-343 , 2020

Link: https://doi.org/10.1177/..

14

The Generalized Data Model for clinical research:

Danese, Mark D. ; Halperin, Marc ; Duryea, Jennifer.
BMC Medical Informatics and Decision Making. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

15

Management of lipid-lowering therapy in patients with cardi..:

Danese, Mark D ; Gleeson, Michelle ; Kutikova, Lucie...
BMJ Open. 7 (2017) 5 - p. e013851 , 2017

Link: https://doi.org/10.1136/..